Saturday 17 October 2026
Export LIVN’s income statement to Excel — free account
LivaNova PLC
LIVN Healthcare Medical Devices
LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024. In the quarter to June 2026, revenue grew 10.8%, EPS grew 296.0%, free cash flow fell 26.7% and total debt fell 31.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
77.60
0.90
−1.15%
Follow LIVN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 4 | 6 | 8 |
| (17.63%) | (19.24%) | 9.54% | 15.40% | ||
| (8.56%) | (9.49%) | 4.22% | 7.33% | ||
ROIC |
12.81% | 13.24% | 12.52% | 10.63% | |
Return on Tangible Assets |
(44.56%) | (45.22%) | 21.12% | 31.88% | |
Average Days of Receivables |
57.25 | 56.80 | 58.38 | 57.37 | |
Free Cash Flow per Share |
3.51 | 3.31 | 3.08 | 2.83 | |
Free Cash Flow |
191.52 | 180.57 | 168.32 | 155.59 | |
Capital Expenditures |
(59.13) | (73.77) | (77.27) | (93.67) | |
| Other line items | |||||
Cash ROIC |
8.56% | 8.16% | 8.26% | 7.29% | |
Accounts Receivable Turnover |
6.60 | 6.79 | 6.65 | 6.52 | |
Accounts Payable Turnover |
5.28 | 5.37 | 4.99 | 4.93 | |
Inventory Turnover |
2.66 | 2.87 | 2.92 | 2.78 | |
Average Days of Payables |
73.35 | 79.12 | 77.64 | 80.38 | |
Days of Inventory on Hand |
139.40 | 134.13 | 129.61 | 134.20 | |
Tax Rate |
0.13 | 0.10 | (0.12) | 0.76 | |
Research and Development Expense of Revenue |
13.12% | 13.38% | 14.41% | 14.48% | |
Selling, General and Administrative Expense of Revenue |
39.43% | 39.54% | 39.29% | 39.66% | |
Share Based Compensation of Revenue |
2.51% | 2.61% | 2.57% | 3.02% | |
Interest Coverage |
3.41 | 4.05 | 4.55 | 5.43 | |
Operating CF/Net income |
(1.15) | (1.05) | 2.29 | 1.32 | |
Depreciation/Fixed assets |
0.37 | 0.34 | 0.32 | 0.31 | |
Capex/Depreciation |
(0.73) | (0.89) | (0.93) | (1.10) | |
Revenue per Share |
24.69 | 25.45 | 26.21 | 26.77 | |
Operating CF per Share |
4.59 | 4.66 | 4.49 | 4.53 | |
Capex per Share |
(1.08) | (1.35) | (1.41) | (1.70) | |
Capex to Sales |
0.04 | 0.05 | 0.05 | 0.06 |
Columns are period end dates